SEC Form 4 · accession 0001493152-18-010342
ProPhase Labs, Inc. · PRPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis Gleckel M.D.
Director
Period of report
Jul 19, 2015
Accepted (ET)
Jul 23, 2018 · 10:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000868278
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0005F1 | Jul 19, 2018 | A | 3,737 | $3.01 | A | 82,972 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors.